首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1812491

抗真菌藥物市場：按藥物類型、適應症、劑型、分銷管道和地區分類

Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2025年08月20日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

抗真菌藥物市場規模預計在 2025 年達到 150 億美元，預計到 2032 年將達到 190.8 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 3.5%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	150億美元
效能數據	2020-2024	預測期	2025-2032
預測期內的複合年成長率（2025-2032）	3.50%	預計金額（2032年）	190.8億美元

抗真菌藥物用於治療個別真菌感染疾病。常見的真菌感染疾病，例如甲真菌感染疾病和癬，通常發生在身體外部，而某些侵襲性真菌感染疾病則發生在身體組織或內臟器官內，例如肺和腦。真菌感染疾病通常更常見於免疫力較弱的人群，例如愛滋病毒/愛滋病患者。接受化療的患者也更容易受到侵襲性真菌感染。抗真菌藥物物透過殺死真菌細胞或抑制其生長發揮作用。抗真菌藥物抗真菌藥物、口服抗真菌藥物、靜脈注射抗真菌藥物及陰道抗黴菌藥栓。

市場動態

市場主要企業正專注於建立合作夥伴關係和簽訂協議等成長策略，以提升其市場影響力。例如，2017年6月，生物製藥公司巴塞利亞製藥有限公司（Basilea Pharmaceutica Ltd.）與輝瑞公司（Pfizer, Inc.）和阿維爾製藥公司（Avir Pharma, Inc.）簽署了一項協議，獲得了抗真菌藥物巴塞利亞的分銷權。輝瑞將在俄羅斯、以色列、歐洲（北歐除外）和土耳其等地區生產和分銷該藥物，用於治療危及生命的侵襲性真菌感染疾病。

同樣，市場主要參與者正專注於各種商業策略，例如研發，以擴大產品系列。預計藥物開發的不斷增加將推動該市場的成長。例如，2019年1月，生物技術公司SCYNEXIS, Inc.宣布其正在進行的FURI試驗的首次中期療效分析取得了積極的中期結果。這項新的治療進展適用於抗真菌治療。

本報告的主要特點

本報告對全球抗真菌藥物市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和復合年成長率。
它還強調了每個細分市場中的潛在商機，並描述了該市場的一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球抗真菌藥物市場的主要企業已根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務績效和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
《全球抗真菌藥物市場》報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球抗真菌藥物市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 15 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	3.50%	2032 Value Projection:	USD 19.08 Bn

Antifungal drugs are used to treat fungal infections in individuals. Common fungal infections such as fungal nail infection, and ringworm etc. usually occur on the external surface of the body, while certain invasive fungal infections occur inside the body tissues or inside internal organs such as lungs and brain. Fungal infection is usually associated with individuals having weak immune system, such as people suffering from HIV/AIDS. Moreover, patients undergoing chemotherapy are susceptible to invasive fungal infections. Antifungal drugs act against the fungal infections by either killing the fungal cells or by inhibiting their growth. Antifungal drugs are broadly classified as topical antifungals, oral antifungals, intravenous antifungals, and intravaginal antifungal pessaries.

Market Dynamics

Major players in the market are focused on growth strategies such as collaborations and agreements in order to enhance their market presence. For instance, in June 2017, Basilea Pharmaceutica Ltd., a biopharmaceutical company, entered into an agreement with Pfizer, Inc. and Avir Pharma, Inc. for the distribution rights of Beasilea's antifungal treatments. Pfizer will manufacture and distribute drugs for the treatment of life-threatening invasive mold infections in regions like Russia, Israel, Europe (excluding Nordics), and Turkey.

Similarly, key players in the market are focused on various business strategies such as research and development in order to expand their product portfolio. Increasing drug development is expected to drive growth of this market. For instance, in January 2019, SCYNEXIS, Inc., a biotechnology company, announced positive interim result from their first interim efficiency analysis of an ongoing FURI study. The development of this novel treatment is indicated for antifungal treatment.

Key features of the study

This report provides an in-depth analysis of global antifungal drugs market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global antifungal drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global antifungal drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antifungal drugs market.

Market Segmentation

By Drug Type
- Echinocandins
- Polyenes
- Allylamines
- Azoles
- Others
By Application
- Neurosurgery
- Plastic Surgery
- Cardiovascular Surgery
- Obstetrics & Gynecology
- Others
By Indication
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Mucormycosis
- Others
By Dosage Form
- Powders
- Ointments
- Injections
- Tablets
- Others
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline Plc
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc.
- Glenmark Pharmaceuticals Limited
- Enzon Pharmaceuticals, Inc.
- Pfizer Inc.
- Gilead Sciences, Inc.
- Sanofi S.A.
- Astellas Pharma, Inc.
- Alembic Pharmaceuticals Limited
- SCYNEXIS, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Anti Fungal Drugs Market, By Drug Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Allylamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends

5. Global Anti Fungal Drugs Market, By Indication, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Aspergillosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Dermatophytosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Mucormycosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
- Segment Trends

6. Global Anti Fungal Drugs Market, By Dosage Form, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Powders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

7. Global Anti Fungal Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Bn)

8. Global Anti Fungal Drugs Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2020 - 2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline Plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bayer AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Glenmark Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Enzon Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gilead Sciences, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sanofi S.A.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Astellas Pharma, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Alembic Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- SCYNEXIS, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

10. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

抗真菌藥物市場－全球產業規模、佔有率、趨勢、機會和預測，按藥物類別、適應症、感染類型、給藥途徑、最終用戶、配銷通路、地區和競爭情況分類，2020 年至 2030 年

酮康唑市場：現況分析與預測（2023-2030）

FAQ

抗真菌藥物市場：按藥物類型、適應症、劑型、分銷管道和地區分類